azomycin has been researched along with Lung Neoplasms in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 34 (41.46) | 18.7374 |
1990's | 7 (8.54) | 18.2507 |
2000's | 7 (8.54) | 29.6817 |
2010's | 33 (40.24) | 24.3611 |
2020's | 1 (1.22) | 2.80 |
Authors | Studies |
---|---|
Cheng, W; Jia, T; Miao, R; Shao, J; Zeng, L; Zhang, C; Zhang, J; Zhao, Y; Zhu, H | 1 |
Dąbrowski, JM; Elas, M; Gonet, M; Karwicka, M; Pucelik, B | 1 |
Bol, A; Di Perri, D; Geets, X; Hanin, FX; Janssens, G; Labar, D; Lee, JA; Robert, A; Sterpin, E | 2 |
Bettinardi, V; Compierchio, A; Doglioni, C; Fallanca, F; Gianolli, L; Incerti, E; Mapelli, P; Masiello, V; Negri, G; Picchio, M; Rossetti, F | 1 |
Bettinardi, V; Coliva, A; Compierchio, A; Doglioni, C; Fallanca, F; Gianolli, L; Incerti, E; Mapelli, P; Negri, G; Picchio, M; Rossetti, F; Savi, A | 1 |
Brolo, AG; Hindi, MN; Jirasek, A; Lum, JJ; Nicholson, LM; Pavey, N; Van Nest, SJ | 1 |
Bahce, I; Boellaard, R; Lammertsma, AA; Raijmakers, P; Schuit, RC; Smit, EF; van Velden, FH; Verwer, EE; Windhorst, AD; Yaqub, M | 1 |
Bollineni, VR; de Groot, EH; Groen, HJ; Kerner, GS; Koole, MJ; Langendijk, JA; Luurtsema, G; Pruim, J; Steenbakkers, RJ; Widder, J; Wiegman, EM; Willemsen, AT | 1 |
Hu, M; Kong, L; Mu, D; Xing, L; Yang, G; Yang, W; Yu, J | 1 |
Ball, D; Binns, D; Blum, R; Bressel, M; Callahan, J; Eu, P; Hicks, RJ; MacManus, MP; Rischin, D; Roselt, P; Segard, T; Trinkaus, ME | 1 |
Cerecetto, H; Dematteis, S; Fernández, S; Giglio, J; Rey, A | 1 |
Bahce, I; Boellaard, R; Hoekstra, OS; Lammertsma, AA; Raijmakers, P; Schuit, RC; Smit, EF; van Velden, FH; Verwer, EE; Windhorst, AD; Yaqub, M | 1 |
Bollineni, VR; Brouwer, CL; Groen, HJ; Halmos, GB; Koole, MJ; Langendijk, JA; Oosting, SF; Pruim, J; Steenbakkers, RJ; Vlasman, R; Widder, J; Wiegman, EM | 1 |
Duan, X; Li, J; Li, XF; Ma, Y; Postel, GC; Wang, F; Wang, X; Yin, X; Zhang, G; Zheng, H | 1 |
Biemans, R; Dubois, LJ; Hart, CP; Lambin, P; Lieuwes, NG; Peeters, SG; Sun, JD; van Elmpt, W; van Stiphout, RG; Windhorst, AD; Yaromina, A; Zegers, CM | 1 |
Brunetti, JC; Chien, D; Kolb, H; Lambin, P; Moon, DH; Srinivas, SM; Subramaniam, RM; Szardenings, K; van Elmpt, W; Waxman, A; Zegers, CM | 1 |
Horiike, A; Inubushi, M; Koizumi, M; Nishio, M; Ohyanagi, F; Saga, T; Tanimoto, K; Yanagitani, N; Yoshikawa, K; Zhang, MR | 1 |
Das, M; Dingemans, AC; Even, AJG; Lambin, P; Mottaghy, FM; Oellers, M; Reymen, B; Troost, EGC; van Elmpt, W; Wildberger, JE; Zegers, CML | 1 |
Bahce, I; Boellaard, R; de Langen, AJ; Hoekstra, OS; Huisman, MC; Iqbal, R; Kramer, GM; Lammertsma, AA; van Velden, FH; Verwer, EE; Windhorst, AD | 1 |
Asamura, H; Fujii, H; Hayashi, Y; Kamiyama, I; Kinoshita, T; Ohtsuka, T | 1 |
Ahluwalia, D; Ferraro, DJ; Hart, CP; Jung, D; Liu, Q; Matteucci, MD; Sun, JD; Wang, Y | 1 |
Chu, T; Lin, X; Luo, R; Luo, Z; Wang, Y; Yang, Z; Zhu, H | 1 |
Hu, X; Huang, Y; Wang, S; Wei, Y; Yu, J; Yu, Q; Yuan, S; Zhao, S; Zhao, W; Zhu, S | 1 |
Ikemura, Y; Kurihara, R; Tanabe, K | 1 |
Chen, Q; Guan, Y; Li, X; Liu, S; Zhang, Q | 1 |
Abrams, DN; Kumar, P; McEwan, AJ; Postema, EJ; Riauka, TA; Richmond, DA; Wiebe, LI | 1 |
Ali, M; Babur, M; Bloomer, WD; Cawthorne, C; Julyan, PJ; Lunt, SJ; Papadopoulou, MV; Price, PM; Smigova, A; Stratford, IJ; Telfer, BA; Williams, KJ | 1 |
An, H; Engenhart-Cabillic, R; Eul, BG; Fokas, E; Hänze, J; Heverhagen, JT; Kamlah, F; Keil, B; Lang, N; Rose, F | 1 |
Fu, Z; Han, AQ; Hu, M; Kong, L; Ma, L; Yang, GR; Yang, WF; Yu, JM; Zhao, SQ; Zheng, JS | 1 |
Hu, M; Li, L; Yang, G; Yu, J; Zhao, W; Zhu, H | 1 |
Cecic, IK; Erler, JT; Felsher, D; Giaccia, AJ; Graves, EE; Le, QT; Sayles, L; Sweet-Cordero, A; Tran, PT; Vilalta, M | 1 |
Ellingsen, C; Galappathi, K; Ovrebø, KM; Rofstad, EK | 1 |
Barber, PR; Bell, A; Burke, M; Daley, FM; Finch, J; Goh, V; Hoskin, PJ; Kozarski, R; Mandeville, HC; Ng, QS; Pierce, G; Townsend, ER; Vojnovic, B | 1 |
Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B | 1 |
Ashino, H; Hazato, T; Hori, H; Inayama, S; Nagasawa, H; Shimamura, M; Uto, Y; Yamamoto, Y | 1 |
Büchler, MW; Büchler, P; Friess, H; Hines, OJ; Lavey, RS; Reber, HA; Tomlinson, J | 1 |
Binns, D; Cullinane, C; Hicks, RJ; McArthur, GA; Roselt, P; Solomon, B; Weibe, LI | 1 |
Fukuda, H; Funaki, Y; Furumoto, S; Hakamatsuka, T; Ishikawa, Y; Ito, M; Iwata, R; Jingu, K; Kaneta, T; Nakata, E; Nakayama, K; Takahashi, S; Takai, Y; Tsujitani, M; Watanuki, S; Yamada, S; Yasuda, H | 1 |
Ito, M; Iwata, R; Kaneta, T; Nakayama, K; Sasaki, T; Takahashi, S; Takai, Y; Tsujitani, M; Yamada, S; Yamaya, M; Yanagihara, K; Yasuda, H | 1 |
Hansen, HS; Hansen, JM; Kamieniecka, Z; Køhler, O; Melgaard, B; Paulson, OB; Pedersen, AG; Tang, X; Trojaborg, W | 1 |
Heller, EH; Mameghan, H | 1 |
Chaplin, DJ; Jinks, S; Millar, BC | 1 |
Byhardt, RW; Cox, JD; Greenberg, M; Komaki, R | 1 |
Hansen, HH; Kjaer, M; Panduro, J; Wolff-Jensen, J | 1 |
Hunter, N; Ito, H; Milas, L | 1 |
Onoyama, Y | 1 |
Clarke, C; Dawson, KB; Sheldon, PW; Simmons, DJ; Simpson, W | 1 |
Irvin, CG; Nierenburg, M; Rockwell, S | 1 |
Adams, GE; Ahmed, I; Chaplin, DJ; Sheldon, PW | 1 |
Breccia, A; Busutti, L; Gattavecchia, E; Stagni, G | 1 |
Mitsuhashi, N; Mogi, K; Nakajima, N; Niibe, H; Okazaki, A; Saito, K; Sakaino, K; Sudo, H; Suzuki, Y; Yonome, I | 1 |
Asakura, H; Kanazawa, A; Maruhashi, A; Mashima, Y | 1 |
Adams, GE; Ahmed, I; Chaplin, DJ; Sheldon, PW; Stratford, IJ | 1 |
Bleehen, NM; Jones, DH; Walton, MI; Workman, P | 1 |
Abe, M; Dodo, Y; Ono, K; Takahashi, M | 1 |
Abe, M; Dodo, Y; Hiraoka, M; Jo, S; Nishidai, T; Ono, K; Takahashi, M | 1 |
Asakawa, H; Hoshino, T; Watarai, J | 1 |
Kylmämaa, TT; Mäntylä, MJ; Nordman, EM; Ruotsalainen, PJ | 1 |
Carella, RJ; Concannon, JP; Perez, CA; Phillips, TL; Simpson, JR | 1 |
Hansen, HS; Kamieniecka, Z; Melgaard, B; Paulson, OB; Pedersen, AG; Tang, X; Trojaborg, W | 1 |
Kochanski, K; Siemann, DW | 1 |
Courtenay, VD; Mills, J; Peacock, JH; Rose, CM; Spooner, D; Stephens, TC | 1 |
Allalunis, MJ; Meeker, BE; Pedersen, JE; Turner, AR; Urtasun, RC | 1 |
Chapman, JD; Golberg, LE; Groshar, D; Hoskinson, M; Mannan, RH; McEwan, AJ; Mercer, JR; Parliament, MB; Urtasun, RC; Wiebe, LI | 1 |
Cherif, A; Harrod, VL; Inoue, T; Kim, CG; Kim, EE; Kuang, LR; Newman, RA; Nornoo, A; Podoloff, DA; Wallace, S; Yang, DJ | 1 |
Hori, H; Inayama, S; Inomata, T; Kasai, S; Kuwasaka, H; Nagasawa, H; Nishioka, A; Ogawa, Y; Oshodani, T; Yoshida, S | 1 |
Hamada, N; Hori, H; Inayama, S; Inomata, T; Itoh, S; Kariya, S; Nagasawa, H; Nishioka, A; Ogawa, Y; Yoshida, S | 1 |
Hori, H; Inayama, S; Inomata, T; Kasai, S; Kuwasaka, H; Masui, M; Nagasawa, H; Oka, S; Oshodani, T; Uto, Y; Yamashita, M | 1 |
Guérin, RA | 1 |
Peckham, MJ; Stanley, JA; Steel, GG | 1 |
Dawen, PJ; Peckham, MJ; Steel, GG | 1 |
Bugden, RD; Peckham, MJ; Pedersen, JE; Smith, MR | 1 |
Ash, DV; Peckham, MJ; Steel, GG | 1 |
Dische, S; Errington, LM; Gray, AJ; Thomlinson, RH | 1 |
Chapman, JD; Golberg, L; Mannan, RH; McEwan, AJ; Mercer, JR; Parliament, MB; Urtasun, RC; Wiebe, LI | 1 |
Bertoni, F; Breccia, A; Busutti, L; Falcone, F; Ferri, E | 1 |
Bleehen, NM; Newman, HF; Smithen, CE; Ward, R; Workman, P | 1 |
Canal, P; Laurent, F; Soula, G | 1 |
Chapman, JD; Kanclerz, A | 1 |
Abe, M; Fushiki, M; Nishidai, T; Ono, K; Sasai, K; Shibamoto, Y; Takahashi, M; Tsutsui, K | 1 |
1 review(s) available for azomycin and Lung Neoplasms
Article | Year |
---|---|
Radiation sensitizers.
Topics: Animals; Antineoplastic Agents; Bromodeoxycytidine; Bromodeoxyuridine; Carcinoma; Deoxyuridine; Dogs; Dose-Response Relationship, Radiation; Floxuridine; Humans; Hypoxia; Idoxuridine; Lung Neoplasms; Methotrexate; Metronidazole; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Research; Sarcoma, Experimental; Skin | 1976 |
16 trial(s) available for azomycin and Lung Neoplasms
Article | Year |
---|---|
Hypoxia imaging with 18F-fluoroerythronitroimidazole integrated PET/CT and immunohistochemical studies in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Glucose; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Nitroimidazoles; Positron-Emission Tomography; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Chemoradiotherapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Repeatability of hypoxia PET imaging using [¹⁸F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial.
Topics: Aged; Biological Transport; Cell Hypoxia; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Triazoles | 2015 |
Prognostic value of (18) F-fluoroazomycin arabinoside PET/CT in patients with advanced non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Nitroimidazoles; Oxygen; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triazoles | 2016 |
Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Humans; Ifosfamide; Lung Neoplasms; Mice; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Xenograft Model Antitumor Assays | 2016 |
A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
Topics: Adult; Aged; Demography; Female; Humans; Hypoxia; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Tissue Distribution | 2016 |
Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Glioma; Head and Neck Neoplasms; Humans; Hypoxia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2009 |
Misonidazole neuropathy.
Topics: Aged; Female; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Peripheral Nerves; Peripheral Nervous System Diseases; Pharyngeal Neoplasms | 1984 |
Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. A double-blind randomized trial.
Topics: Aged; Carcinoma, Squamous Cell; Double-Blind Method; Esophagitis; Humans; Lung Neoplasms; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Placebos; Pneumonia; Radiation Injuries; Radiotherapy Dosage; Random Allocation; Vomiting | 1983 |
[Clinical trials of hypoxic cell sensitizer misonidazole].
Topics: Brain Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Misonidazole; Neoplasms; Nitroimidazoles; Oxygen; Random Allocation; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1983 |
[Biological and physical approach to the improvement of radiotherapy].
Topics: Animals; Cell Survival; Hot Temperature; Humans; Lung Neoplasms; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiotherapy | 1983 |
[Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
Topics: Aged; Esophageal Neoplasms; Female; Humans; Kidney; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Oxygen; Stomach Neoplasms; Tongue Neoplasms; Uterine Cervical Neoplasms | 1984 |
Misonidazole and radiotherapy in lung cancer: a randomized double-blind trial.
Topics: Aged; Carcinoma, Bronchogenic; Clinical Trials as Topic; Double-Blind Method; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Random Allocation | 1982 |
Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.
Topics: Adult; Cell Survival; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin Neoplasms; Soft Tissue Neoplasms | 1976 |
Kinetic uptake of etanidazole in lung carcinoma and normal tissue in vivo.
Topics: Aged; Carcinoma, Bronchogenic; Combined Modality Therapy; Etanidazole; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Radiation-Sensitizing Agents; Reference Values | 1992 |
65 other study(ies) available for azomycin and Lung Neoplasms
Article | Year |
---|---|
Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Humans; Hypoxia; Lung Neoplasms; Nitroimidazoles; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Structure-Activity Relationship | 2023 |
Effects of Photodynamic Therapy with Redaporfin on Tumor Oxygenation and Blood Flow in a Lung Cancer Mouse Model.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Kaplan-Meier Estimate; Lung Neoplasms; Mice, Inbred C57BL; Nitroimidazoles; Oxygen; Perfusion; Photochemotherapy; Porphyrins; Sulfonamides; Tissue Distribution; Tumor Hypoxia; Vascular Endothelial Growth Factor A | 2019 |
Evolution of [
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage | 2017 |
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT.
Topics: Aged; Gastrointestinal Stromal Tumors; Humans; Lung Neoplasms; Male; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Tumor Hypoxia | 2017 |
Correlation analysis of [
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma | 2017 |
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals | 2018 |
Raman spectroscopy detects metabolic signatures of radiation response and hypoxic fluctuations in non-small cell lung cancer.
Topics: Animals; Antigens, Neoplasm; Carbonic Anhydrase IX; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glycogen; Histones; Humans; Lung Neoplasms; Mice; Mice, Inbred NOD; Neoplasm Transplantation; Nitroimidazoles; Radiation Dosage; Spectrum Analysis, Raman; Treatment Outcome | 2019 |
Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Humans; Kinetics; Lung Neoplasms; Male; Middle Aged; Models, Biological; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitroimidazoles; Positron-Emission Tomography; Tumor Burden | 2013 |
Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
Topics: Animals; Biological Transport; Blood Proteins; Cell Hypoxia; Cell Line, Tumor; Chemical Phenomena; Chemistry Techniques, Synthetic; Drug Stability; Female; Hydrophobic and Hydrophilic Interactions; Ligands; Lung Neoplasms; Mice; Molecular Imaging; Nitroimidazoles; Organotechnetium Compounds; Radiopharmaceuticals; Tissue Distribution | 2014 |
Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patients.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Humans; Kinetics; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Hypoxia; Chemoradiotherapy; Cohort Studies; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Nitroimidazoles; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
Topics: Animals; Blood Glucose; Body Weight; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Diet; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment | 2015 |
TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Chemoradiotherapy; Imidazoles; Lung Neoplasms; Nitroimidazoles; Phosphoramide Mustards; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Treatment Outcome; Triazoles; Xenograft Model Antitumor Assays | 2015 |
Multiparametric Analysis of the Relationship Between Tumor Hypoxia and Perfusion with ¹⁸F-Fluoroazomycin Arabinoside and ¹⁵O-H₂O PET.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cluster Analysis; Female; Humans; Hypoxia; Lung Neoplasms; Male; Middle Aged; Neoplasms; Nitroimidazoles; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Water | 2016 |
Prognostic significance of hypoxic PET using (18)F-FAZA and (62)Cu-ATSM in non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Coordination Complexes; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Thiosemicarbazones | 2016 |
Synthesis and radiolabeling of (64)Cu-labeled 2-nitroimidazole derivative (64)Cu-BMS2P2 for hypoxia imaging.
Topics: Animals; Cell Hypoxia; Coordination Complexes; Copper Radioisotopes; Isotope Labeling; Lung Neoplasms; Mice; Molecular Imaging; Molecular Structure; Neoplasms, Experimental; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Preparation of alkyne-labeled 2-nitroimidazoles for identification of tumor hypoxia by Raman spectroscopy.
Topics: A549 Cells; Alkynes; Cell Hypoxia; Humans; Lung Neoplasms; Molecular Probes; Nitroimidazoles; Spectrum Analysis, Raman | 2016 |
Synthesis and Biological Evaluation of a New Nitroimidazole-99mTc-Complex for Imaging of Hypoxia in Mice Model.
Topics: A549 Cells; Animals; Biological Availability; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; Humans; Imino Acids; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nitroimidazoles; Organotechnetium Compounds; Radiopharmaceuticals | 2016 |
The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cell Line, Tumor; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation, Preclinical; Imidazoles; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasm Metastasis; Nitroimidazoles; Quinolines; Sarcoma; Tirapazamine; Triazines | 2010 |
Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
Topics: Adenocarcinoma; Animals; Apoptosis; Benzimidazoles; Biomarkers; Caspase 3; Cell Hypoxia; Contrast Media; Gadolinium; Glucose Transporter Type 1; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Nitroimidazoles; Platelet Endothelial Cell Adhesion Molecule-1; Time Factors; Transplantation, Heterologous | 2010 |
[Value of 18F-FETNIM PET-CT for detection of tumor hypoxia in non-small-cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2010 |
Hypoxia in models of lung cancer: implications for targeted therapeutics.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Electrodes; Histones; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasms, Experimental; Nitrogen Mustard Compounds; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; ras Proteins | 2010 |
Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Topics: Animals; Biomarkers, Tumor; Cell Hypoxia; Contrast Media; Female; Gadolinium DTPA; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Transplantation, Heterologous; Tumor Microenvironment | 2012 |
Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia.
Topics: Aged; Biomarkers, Tumor; Blood Volume; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Humans; Hypoxia; Immunohistochemistry; Iohexol; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nitroimidazoles; Prospective Studies; Radiation-Sensitizing Agents; Radiographic Image Interpretation, Computer-Assisted; Statistics, Nonparametric; Tomography, Spiral Computed | 2012 |
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment | 2012 |
A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Cattle; Cell Division; Chick Embryo; Chorion; Endothelial Growth Factors; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Hydroxamic Acids; Hypoxia; Imidazoles; Injections, Intraperitoneal; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Mice; Neovascularization, Pathologic; Nitro Compounds; Nitroimidazoles; Pulmonary Artery; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model.
Topics: Abdominal Neoplasms; Animals; Cell Hypoxia; Cell Line, Tumor; Disease Progression; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Nitroimidazoles; Oxygen; Pancreatic Neoplasms; Partial Pressure; Staining and Labeling | 2004 |
Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Fluorine Radioisotopes; Gefitinib; Humans; Hypoxia; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nitroimidazoles; Oxidation-Reduction; Oxygen; Positron-Emission Tomography; Quinazolines; Tissue Distribution | 2005 |
Initial evaluation of dynamic human imaging using 18F-FRP170 as a new PET tracer for imaging hypoxia.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Organ Specificity; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Whole Body Imaging | 2007 |
Tumor hypoxia imaging with [F-18] fluoronitroimidazole in non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Humans; Hypoxia; Lung Neoplasms; Male; Nitroimidazoles; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2007 |
Misonidazole & radiotherapy in the palliative treatment of lung cancer.
Topics: Administration, Oral; Aged; Carcinoma, Bronchogenic; Drug Evaluation; Female; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Palliative Care | 1983 |
Studies on the protection against misonidazole-induced toxicity by antiinflammatory agents.
Topics: Animals; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dexamethasone; Female; Flurbiprofen; Lung; Lung Neoplasms; Mice; Mice, Inbred Strains; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Phospholipases; Phospholipases A; Propionates | 1983 |
Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Misonidazole; Mouth Neoplasms; Nitroimidazoles; Oropharynx; Pharyngeal Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Retrospective Studies | 1980 |
Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Topics: Amifostine; Animals; Cyclophosphamide; Drug Interactions; Drug Therapy, Combination; Extremities; Female; Fibrosarcoma; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Time Factors | 1983 |
Intestinal microflora as potential modifiers of sensitizer activity in vivo.
Topics: Animals; Bacteria; Body Temperature; Combined Modality Therapy; Drug Synergism; Female; Intestines; Lung Neoplasms; Melphalan; Mice; Misonidazole; Nitroimidazoles; Penicillins; Radiation-Sensitizing Agents | 1984 |
Enhancement of artificial lung metastases by misonidazole.
Topics: Animals; Cell Line; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1984 |
Clinical trials with cyclophosphamide and misonidazole combination for maintaining treatment after radiation therapy of lung carcinoma.
Topics: Adult; Aged; Combined Modality Therapy; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
[Clinical evaluation of radiosensitizing effects of misonidazole].
Topics: Brain Neoplasms; Combined Modality Therapy; Drug Evaluation; Esophageal Neoplasms; Humans; Lung Neoplasms; Misonidazole; Nitroimidazoles | 1984 |
[Radiotherapy in combination with misonidazole and ACNU in lung neoplasms].
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nimustine; Nitroimidazoles; Nitrosourea Compounds; Radiotherapy Dosage | 1983 |
Radiosensitization in vivo: a study with an homologous series of 2-nitroimidazoles.
Topics: Animals; Carcinoma; Cell Survival; Cells, Cultured; Drug Evaluation, Preclinical; Lung Neoplasms; Mice; Mice, Inbred C57BL; Nitroimidazoles; Radiation-Sensitizing Agents; Structure-Activity Relationship; Time Factors | 1983 |
The role of dexamethasone in the modification of misonidazole pharmacokinetics.
Topics: Adult; Aged; Dexamethasone; Drug Interactions; Female; Humans; Kinetics; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Misonidazole; Nitroimidazoles; Phenobarbital; Phenytoin | 1983 |
[Clinical study on radiotherapy in combination with misonidazole].
Topics: Aged; Esophageal Neoplasms; Female; Humans; Lung Neoplasms; Middle Aged; Misonidazole; Neoplasms; Nitroimidazoles; Pharyngeal Neoplasms; Radiation-Sensitizing Agents | 1983 |
Large fraction radiotherapy plus misonidazole for treatment of advanced lung cancer: report of a phase I/II trial.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Radiotherapy; Radiotherapy Dosage | 1982 |
Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.
Topics: Aged; Carcinoma, Squamous Cell; Electromyography; Female; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Median Nerve; Middle Aged; Misonidazole; Nerve Fibers, Myelinated; Nervous System Diseases; Neural Conduction; Neuromuscular Diseases; Nitroimidazoles; Paresthesia; Peroneal Nerve; Pharyngeal Neoplasms; Sensation; Sural Nerve; Tibial Nerve | 1982 |
Combinations of radiation and misonidazole in a murine lung tumor model.
Topics: Animals; Cell Survival; Dose-Response Relationship, Radiation; Female; Lung; Lung Neoplasms; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Radiotherapy; Sarcoma, Experimental; Time Factors | 1981 |
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Pancreatic Neoplasms; Transplantation, Heterologous | 1981 |
Cytotoxic and radiosensitizing effects of misonidazole on hematopoiesis in normal and tumor-bearing mice.
Topics: Animals; Colony-Forming Units Assay; Dose-Response Relationship, Radiation; Hematopoiesis; Hematopoietic Stem Cells; Hypoxia; Lung Neoplasms; Male; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles | 1980 |
Imaging tumor hypoxia and tumor perfusion.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Glioblastoma; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Nitroimidazoles; Organotechnetium Compounds; Oximes; Sarcoma; Soft Tissue Neoplasms; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |
Development of new markers for hypoxic cells: [131I]Iodomisonidazole and [131I]Iodoerythronitroimidazole.
Topics: Animals; Breast Neoplasms; Cell Hypoxia; Female; Iodine Radioisotopes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radionuclide Imaging; Rats; Rats, Inbred F344; Tissue Distribution; Tumor Cells, Cultured | 1996 |
TX-1877: design, synthesis, and biological activities as a BRM-functional hypoxic cell radiosensitizer.
Topics: Animals; Cell Hypoxia; Drug Design; Female; Immunologic Factors; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1998 |
Lung metastasis suppression of the bifunctional new radiosensitizer KIN-806.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Gamma Rays; Lung Neoplasms; Mice; Mice, Inbred Strains; Molecular Structure; Nitroimidazoles; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1999 |
New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Drug Design; Electrochemistry; Female; Hypoxia; Leukocytes, Mononuclear; Lung Neoplasms; Macrophages; Mice; Mice, Inbred C3H; Models, Molecular; Neoplasm Metastasis; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
[The use of potentiating agents in megavoltage therapy of non-resected localized carcinoma of the lung (author's transl)].
Topics: Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Hot Temperature; Humans; Lung Neoplasms; Neutrons; Nitroimidazoles; Radiotherapy, High-Energy | 1979 |
Influence of tumour size on radiosensitization by misonidazole.
Topics: Animals; Cell Survival; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1978 |
The response of human tumour metastases to radiation and misonidazole.
Topics: Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Nitroimidazoles; Radiation-Sensitizing Agents; Skin Neoplasms | 1978 |
Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
Topics: Animals; Cell Survival; Guinea Pigs; Lung Neoplasms; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Tissue Distribution | 1979 |
The quantitative response of human tumours to radiation and misonidazole.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Radiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Skin Neoplasms | 1979 |
Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.
Topics: Adult; Aged; Carcinoma, Small Cell; Female; Half-Life; Humans; Hypoxia; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Neoplasms; Nitroimidazoles; Tomography, Emission-Computed | 1992 |
Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in man.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Radiation-Sensitizing Agents; Stereoisomerism | 1991 |
Pharmacokinetics of Ro 03-8799 in mice bearing melanosarcoma: comparison with tumors without melanin.
Topics: Animals; Lung Neoplasms; Melanins; Melanoma, Experimental; Mice; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1989 |
Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice.
Topics: Amifostine; Animals; Etanidazole; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Metastasis; Neoplasms, Experimental; Nitroimidazoles; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1988 |
[Present status of hypoxic cell sensitizers and PLDR inhibitors].
Topics: Animals; Cell Cycle; Cell Line; Etanidazole; Humans; Lung Neoplasms; Misonidazole; Nitroimidazoles; Radiation Tolerance; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1987 |